Govt Job: For M.Pharm, M.Sc as Senior Research Fellow in AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object to develop patterns of teaching Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India;

  • To bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity
  • To attain self-sufficiency in Post-graduate Medical Education.

Post: Senior Research Fellow (SRF)

Applications are invited for the post of Senior Research Fellow (SRF) in an ICMR-funded project (Project code: 1-1331) entitled “Genetic expression of monoaminergic neurotransmission related polymorphisms and their association with antidepressant response in Indian patients suffering from depression.” with a project duration of 3 years.

Minimum Qualifications: M.Sc, (Life Sciences / Pharmacology) degree holders with two years of research experience.

OR MBBS/BDS/ M.Pharm. degree holders Desirable qualification:

Experience in qRT-PCR-based techniques and clinical studies
Monthly emoluments: Rs. 35,000/- pm+ HRA permissible as per rule

Age Limit: Up to 35 years

Interested candidates are required to submit their applications with a CV by email to “neuropharmalab5002@gmail.com” or directly at 5th Floor, Room No. 5002, Convergence Block, Department of Pharmacology, AIIMS, New Delhi.

The shortlisted candidate will be informed about the date and venue of the interview by email of the telephone call.

The last date for submission of applications is October 25th, 2022.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India